Anti-Jo-1 antibodies

被引:55
作者
Zampieri, S [1 ]
Ghirardello, A [1 ]
Iaccarino, L [1 ]
Tarricone, E [1 ]
Gambari, PF [1 ]
Doria, A [1 ]
机构
[1] Univ Padua, Dept Med & Surg Sci, Div Rheumatol, Padua, Italy
关键词
idiopathic inflammatory myopathy; polymyositis; histidyl-tRNA synthetase; anti-Jo-1; antibody; anti-synthetase syndrome;
D O I
10.1080/08916930400022640
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammatory myopathies (IIM). This antibody is directed against the histidyl-tRNA synthetase which catalyses the binding of the histidine to its cognate tRNA during protein synthesis. It can be considered a specific marker of IIM, predominantly found in 20-30% of patients with PM and in the 60-70% of those with interstitial pulmonary fibrosis. These antibodies are also found in DM, although less frequently than in PM, and are rare in children with PM or DM and in other connective tissue diseases. ELISA, CIE and immunoblotting are highly specific and sensitive techniques for testing anti-Jo-1 antibodies. The detection of this antibody is particularly useful in diagnosis and classification of IIM. Moreover, anti-Jo-1 serum levels strongly correlate with disease activity representing a good marker for disease monitoring.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 49 条
  • [1] ARNETT FC, 1981, J RHEUMATOL, V8, P925
  • [2] ADVERSE IMPACT OF INTERSTITIAL PULMONARY FIBROSIS ON PROGNOSIS IN POLYMYOSITIS AND DERMATOMYOSITIS
    ARSURA, EL
    GREENBERG, AS
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1988, 18 (01) : 29 - 37
  • [3] ANTI-JO-1 ANTIBODY - A MARKER FOR MYOSITIS WITH INTERSTITIAL LUNG-DISEASE
    BERNSTEIN, RM
    MORGAN, SH
    CHAPMAN, J
    BUNN, CC
    MATHEWS, MB
    TURNERWARWICK, M
    HUGHES, GRV
    [J]. BRITISH MEDICAL JOURNAL, 1984, 289 (6438) : 151 - 152
  • [4] AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETECTION AND QUANTITATION OF ANTI-JO-1 ANTIBODY IN HUMAN-SERUM
    BISWAS, T
    MILLER, FW
    TAKAGAKI, Y
    PLOTZ, PH
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 98 (02) : 243 - 248
  • [5] POLYMYOSITIS AND DERMATOMYOSITIS .1.
    BOHAN, A
    PETER, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) : 344 - 347
  • [6] Brouwer R, 1998, ARTHRITIS RHEUM, V41, P1428, DOI 10.1002/1529-0131(199808)41:8<1428::AID-ART12>3.0.CO
  • [7] 2-J
  • [8] Autoantibody profiles in the sera of European patients with myositis
    Brouwer, R
    Hengstman, GJD
    Egberts, WV
    Ehrfeld, H
    Bozic, B
    Ghirardello, A
    Grondal, G
    Hietarinta, M
    Isenberg, D
    Kalden, JR
    Lundberg, I
    Moutsopoulos, H
    Roux-Lombard, P
    Vencovsky, J
    Wikman, A
    Seelig, HP
    van Engelen, BGM
    van Venrooij, WJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (02) : 116 - 123
  • [9] HISTIDYL-TRANSFER-RNA SYNTHETASE, THE MYOSITIS JO-1 ANTIGEN, IS CYTOPLASMIC AND UNASSOCIATED WITH THE CYTOSKELETAL FRAMEWORK
    DANG, CV
    LADUCA, FM
    BELL, WR
    [J]. EXPERIMENTAL CELL RESEARCH, 1986, 164 (01) : 261 - 266
  • [10] SUBCLASS RESTRICTION AND POLYCLONALITY OF THE SYSTEMIC LUPUS-ERYTHEMATOSUS MARKER ANTIBODY ANTI-SM
    EISENBERG, RA
    DYER, K
    CRAVEN, SY
    FULLER, CR
    YOUNT, WJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (04) : 1270 - 1277